Skip to main content
PMC home page
JBRA Assisted Reproduction logoLink to JBRA Assisted Reproduction
. 2019 Apr-Jun;23(2):83–90. doi: 10.5935/1518-0557.20180079

Protective action of N-acetylcysteine on sperm quality in cyclophosphamide-induced testicular toxicity in male Wistar rats

Seyyid A Shittu 1,✉, Shehu-Tijani Shittu 2, Opeyemi O Akindele 1, Olufadekemi T Kunle-Alabi 1, Yinusa Raji 1
PMCID: PMC6501750  PMID: 30633472

Abstract

Background:

Reductions in sperm quality due to free radical formation during cancer chemotherapy are well documented, hence the need for an adjunct antioxidant treatment during chemotherapy. This study was designed to investigate the effects of N-acetylcysteine on sperm quality following cyclophosphamide exposure in male Wistar rats.

Methods:

Twenty male Wistar rats weighing 150-170g were randomly assigned into 4 groups of five rats each, and were orally administered distilled water (Control), Cyclophosphamide (6mg/kg), N-acetylcysteine (100mg/kg) or Cyclophosphamide + N-acetylcysteine for 21 days. Sperm count, histone-protamine replacement, chromatin integrity, testicular histomorphometry and BAX Protein expression were assessed using standard procedures. The data was presented as mean ± SEM and analyzed using students' t- test. A p<0.05 was considered significant.

Results:

Sperm counts were significantly reduced (p<0.05) among the cyclophosphamide (69.95±7.78 x106/ml) and cyclophosphamide + N-acetylcysteine (64.78±3.52 x106/ml) treated rats, while it increased significantly (p<0.05) in the N-acetylcysteine (132.20±28.71 x106/ml) treated rats compared to the control animals (115.30±8.70x106/ml). Increased interstitial space distance, degenerated Leydig cells and impaired histone-protamine replacement observed among the cyclophosphamide-treated rats were ameliorated in the cyclophosphamide + N-acetylcysteine-treated rats. Sperm chromatin integrity, which was poor in the cyclophosphamide-treated rats, was considerably improved when compared with the Control and the N-acetylcysteine-treated rats. Bax protein expression was reduced in the cyclophosphamide (20%) and cyclophosphamide+N-acetylcysteine (20%) groups when compared with the Control (50%) and N-acetylcysteine (50%) groups.

Conclusion:

We concluded that N-acetylcysteine might improve sperm histone protamine replacement, which is one of the stage-specific effect of cyclophosphamide toxicity.

Keywords: N-acetylcysteine, adjunct drug, sperm quality, chemotherapy

INTRODUCTION

Spermatogenesis is a series of events involving the production of spermatozoa with a characteristic genomic compaction, capable of surviving different environments within the parent organism until fertilization (Montellier et al., 2013). The events are vulnerable to the buildup of errors (Georgiou et al., 2006); thus, sperm must be correctly programmed and packaged to successfully pass on genetic and epigenetic information to the developing embryo. To enhance these processes, sperm undergoes some changes in the chromatin structure by replacing histones within the cell chromatin in a larger percentage with cysteine-rich protamine during spermiogenesis, a process known as protamination (Oliva, 2006). In addition, formation of disulfides through DNA cross-linkages further condense the chromatin, thereby stabilizing the compacted sperm DNA (Calvin & Bedford, 1971). However, abnormal deposition of sperm protamines during spermiogenesis or altered chromatin condensation can lead to enhanced susceptibility to sperm DNA injury (Kosower et al., 1992; Lolis et al., 1996; Codrington et al., 2004). Analysis of possible alterations to DNA integrity has been suggested to be a more objective and better prognostic marker for fertility potential of spermatozoa because it provides evidence of hidden anomalies that might exist even in spermatozoa appearing morphologically normal (Bianchi et al., 1996; Evenson et al., 1999; 2002). Reports have also shown that incorrect DNA integrity and condensation due to failure during spermiogenesis (histone to protamine exchange) seems to be an important factor predicting the outcome of assisted reproduction (Blanchard et al., 1990; Ankem et al., 2002; Steger et al., 2003).

Exposure to toxic alkylating agents, such as some chemotherapeutic agents, among which is cyclophosphamide (Spermon et al., 2006; Codrington et al., 2007), may significantly contribute to the impairment of chromatin compaction, thus increasing the susceptibility of these cells to oxidative or apoptotic attack (Sega, 1990). Cyclophosphamide is widely used to treat malignant and non-malignant tumors (Alyamkina et al., 2010). However, like other chemotherapeutic agents, it produces some side effects such as severe cytotoxicity, hemorrhagic cystitis, and temporary infertility (Wang et al., 2012; Alkam et al., 2014).

N-Acetylcysteine (NAC) is an antioxidant and mucolytic agent used in respiratory illness as well as an antidote for acetaminophen hepatotoxicity. It is recently gaining ground as a complementary therapy for cancer (Arora-Kuruganti et al., 1999; Chiao et al., 2000; Moschou et al., 2008). N-Acetylcysteine has been reported to protect against testicular damage and dysfunction by the attenuation of increased testicular malondialdehyde (MDA) levels and decreased superoxide dismutase, catalase, GSH and glutathione-S-Transferase (GST) levels resulting from tetracycline-induced toxicity in rats (Farombi et al., 2008). It has been reported useful as adjunct antioxidant in acute lymphoblastic leukemia therapy in children (Al-Tonbary et al., 2009), and in cyclophosphamide-induced hemorrhagic cystitis in rats (Jamshidzadeh et al., 2009). However, its probable effect on cyclophosphamide-induced testicular toxicity is yet to be ascertained. Therefore, the aim of this study was to investigate the effects of N-acetylcysteine on sperm count, histone-protamine replacement, chromatin integrity, testicular histomorphometry and BAX Protein expression in cyclophosphamide-induced testicular toxicity in Wistar rats.

MATERIALS AND METHODS

Drugs and Chemicals

Cyclophosphamide (Endoxan tablet, manufactured by Baxter Oncology, Germany) and N-Acetylcysteine (Sandox SA, [Pty] Ltd) were obtained from a local pharmacy store.

Animals

All protocols and procedures adopted in this study adhere strictly to the guidelines of the Animal Rights Committee of the University of Ibadan. Adult male rats weighing between 150g and 170g were procured from the Central Animal House, College of Medicine, University of Ibadan for use in this study. The rats were housed under a standard environmental condition in one of the animal facilities of the Central Animal House with the provision of 12h of light and 12h of darkness, and they were fed with a standard rat chow and allowed access to water and food ad libitum throughout the experiments.

Experimental Groups

The animals were divided into four groups (n=5 per group). Group 1 (control) rats were orally administered with distilled water; Group 2 with cyclophosphamide (6 mg/ kg body weight/ day); Group 3 with N-Acetylcysteine (100 mg/kg body weight/day) and Group 4 with both cyclophosphamide and N-acetylcysteine at their respective dose level for twenty one days.

Testicular histology

The testes of the rats were prefixed in Bouin-Hollande solution prior to the histologic studies using Hematoxylin and Eosin (H&E) Staining Protocol.

Sperm Collection

The cauda epididymal region was removed and transferred to a sterile Petri dish containing 5ml of normal saline. It was thoroughly minced with a sterile scalpel to allow for spermatozoa dispersion.

Sperm Count

For sperm counting at 1:200 dilution, the sperm samples were prepared with normal saline. For this purpose 10 µL of the sperms were added to 190 µL of saline, and then 10 µL of the diluted sperm was dropped on a Neubauer slide and we counted the average number of sperms according to Raji et al. (2005).

Sperm Histone-Protamine replacement

To test for sperm histone-protamine replacement, epididymal sperm smears were made on glass slides. Each of the smears were stained with aniline blue (AB) based on the method described by Wong et al. (2008). Acid aniline blue is a dye that specifes between lysine-rich histone and arginine/cysteine-rich protamine; hence, it reveals the basic nuclear protein composition of spermatozoa. The sperm smears were fixed in 4% formalin solution for 5 min, rinsed in distilled water, and stained in 5% AB in 4% acetic acid (pH 3.5) solution for 5 min. The slides were then washed in distilled water, stained in 0.5% eosin for 1 min and allowed to air-dry. After which, the slides were examined at 400X magnification in a light microscope. Dark blue stained sperm heads were considered immature, characterized by nuclear histone proteins, while colorless sperm heads were considered mature sperm with protamine.

Chromatin Condensation and DNA Integrity

Toluidine blue (TB) is a basic dye used to evaluate both sperm chromatin condensation and DNA integrity (Mello, 1982). For this staining, air-dried smears were fixed in fresh 96% ethanol-acetone (1:1) at 48ºC for 30 min, then hydrolyzed in 0.1 N HCl at 48ºC for 5 min and rinsed thrice in distilled H2O for 2 min. Finally, the smears were stained with 0.05% TB in McIlvain buffer, pH 3.5 (Sigma, St. Louis, MO, USA) for 10 min (Erenpreiss et al., 2001). The sperm cells were assessed by light microscopy at 400X magnification, according to metachromatic staining of sperm heads in the following scores: light blue (Intact chromatin); purple (mildly abnormal chromatin); violet (severe chromatin abnormality) (Rosenborg et al., 1990). The light blue spermatozoa were considered normal cells (TB-) and spermatozoa with violet and purple spermatozoa were considered abnormal ones (TB+).

Immunohistochemistry

Five-micron thick tissue sections were deparaffinized in xylol and hydrated in a decreasing series of ethanol. Endogenous peroxidase activity was blocked by incubation in methanol containing 0.3% H2O2 for 15 min at room temperature, followed by rinsing in 0.1 M phosphate buffered saline (PBS; pH 7.4) for 5 min. The sections were then treated with citrate buffer (pH 6) for 15 min at 98ºC as antigen retrieval. Before application of specific primary antibodies, nonspecific background staining was prevented by incubation with goat serum diluted 1:10 v/v in PBS for 50 min. Then the sections incubated overnight at 4ºC with primary antibodies, including the monoclonal antibody against Bax (Mouse Monoclonal anti-Bax; sc: 7480, Santa Cruz) at 1/100 diluted in PBS containing 10% normal goat serum (NGS). After washing twice with PBS the sections were incubated with secondary antibody biotinylated anti-mouse IgG (Santa Cruz ABC Peroxidase Mouse IgG Staining Kit) at 1/100 for 50 min. Then the specimens were incubated with peroxidase-conjugated avidin biotin for 30 min at room temperature. After washing, the sections were incubated with diaminobenzidine (DAB) as chromogen, and counterstained with hematoxylin. Negative control was performed by omitting the anti-Bax antibody. Mouse thymus was used as a positive control. Two immunohistochemical slides from each animal were blindly assessed, and staining intensity was estimated using a semi-quantitative score, the H-score, as previously described by Pallares et al. (2005). The H-score was calculated for each section by application of the following algorithm: H-SCORE = ΣPi (i+1) (Where i is the intensity of staining (0 - no staining, 1 - weak, 2 - moderate, 3 - strong) and Pi is the percentage of stained cells for each intensity 0 to 100%).

Data Analysis

The data was presented as mean ± SEM and analyzed using students' t- test. p <0.05. was considered significant.

RESULTS

Effects of N-Acetylcysteine on sperm count in Cyclophosphamide treated Rats

The mean sperm count is depicted on Table 1. Rats treated with cyclophosphamide only and the ones that received the cyclophosphamide and N-acetylcysteine combination, respectively, had a significant reduction in sperm; while it increased among the N-acetylcysteine-only treated rats when compared with the control animals.

Table 1.

Effects of N-acetylcysteine on semen characteristics in cyclophosphamide treated rats.

  Sperm count (x106/ml)
Control 115.30±8.70
CP only 69.95±7.78*
NAC only 132.20±28.71
CP + NAC 64.78±3.52*
Open in a new tab
*

P<0.05 when compared to the control

Effects of N-Acetylcysteine on testicular histomorphometry on Cyclophosphamide-Treated Rats

The testicular histomorphometries are shown in Plates 1 A-D. The control animals and the N-acetylcysteine-only treated rats had a normal testicular morphology with a progressive sperm development towards the lumen of the seminiferous tubules, Plate 1A and Plate 1C, respectively. However, the rats treated with cyclophosphamide only (Plate 1B), those treated with a combination of cyclophosphamide, and N-acetylcysteine (Plate 1D) showed degenerated seminiferous tubules, increased interstitial space and degenerated Leydig cells.

Plates 1 .

Plates 1

Open in a new tab

Photomicrographs of testicular tissue showing seminiferous tubules that are lined with germ cells (black arrow) at various stages of maturation to spermatozoa (black triangular box) and their respective interstitial spaces (black star box).

(A) Distilled water only (B) Cyclophosphamide only (C) N-acetylcysteine only (D) Cyclophosphamide + N-acetylcysteine.

Effects of N-Acetylcysteine on Sperm Maturation (Histone Protamine Replacement) in Cyclophosphamide treated rats

The histone-protamine replacement of the rats are shown in Plates 2 A-D. The results showed that except for the group 2 rats treated with cyclophosphamide only, all other groups did not take up the aniline blue stain, indicating that they had a progressive histone-protamine replacement (Plates 2A, 2C, 2D). The uptake of blue stain in group 2 rats treated with cyclophosphamide indicates that they had an impaired histone-protamine replacement with more histone retention (Plate 2B).

Plates 2.

Plates 2

Open in a new tab

Photomicrograph showing the basic nuclear protein in spermatozoa head. (A) Distilled water only (B) Cyclophosphamide only (C) N-acetylcysteine only (D) Cyclophosphamide + N-acetylcysteine.

Effects of N-Acetylcysteine on Chromatin Condensation (DNA Integrity) in Cyclophosphamide-treated rats

Plates 3 A-D show the extent of chromatin condensation and DNA integrity in the respective groups. Normal sperm DNA integrity was found in the control group (Plate 3A) and in the N-acetylcysteine-treated group (Plate 3C). A fair DNA integrity was found in rats treated with the cyclophosphamide and N-acetylcysteine combination (Plate 3D), while a poor DNA integrity was seen in rats treated with cyclophosphamide (Plate 3B).

Plates 3.

Plates 3

Open in a new tab

Photomicrograph showing the spermatozoa chromatin integrity. (A) Distilled water only (B) Cyclophosphamide only (C) N-acetylcysteine only (D) Cyclophosphamide + N-acetylcysteine.

Effects of N-Acetylcysteine on BAX apoptotic protein expression in Cyclophosphamide- treated rats

Plates 4 A-D show the expression of BAX pro-apoptotic protein in the testis. Group 1 treated with distilled water showed a very high expression in about 50% of their seminiferous tubules (Plate 4A), while group 3 rats treated with N-acetylcysteine only showed a moderate expression in about 50% of their seminiferous tubule (Plate 4C). However, a moderate expression of the BAX protein was only seen in about 20% of seminiferous tubules of group 2 rats treated with cyclophosphamide only (Plate 4B) and group 4 (Plate 4D) rats co-administered with cyclophosphamide and N-acetylcysteine.

Plates 4.

Plates 4

Open in a new tab

Photomicrographs showing Immunohistochemical expression of Bax apoptotic protein around the seminiferous tubule: (A) Distilled water only (B) Cyclophosphamide only (C) N-acetylcysteine only (D) Cyclophosphamide + N-acetylcysteine.

DISCUSSION

The aim of this study was to investigate the effects of N-acetylcysteine on sperm quality in cyclophosphamide-induced testicular toxicity. The reduction in sperm count in all animals treated with cyclophosphamide pointed to the impairing effects of cyclophosphamide on germ cell cycle in the testis. This is in line with previous reports on cyclophosphamide as an anticancer drug, with a major side effect of oligospermia in male cancer survivors (Howell et al., 1999).

The degraded seminiferous tubule and Leydig cells observed in cyclophosphamide- treated rats is an evidence of its effects on testicular damage. The non-reversal of this damaged testicular seminiferous tubule in animals treated with cyclophosphamide and N-acetylcysteine indicates that N-acetylcysteine does not inhibits the primary cytotoxic role of cyclophosphamide. However, the improvement in sperm maturation in this group when compared with cyclophosphamide-treated group shows that N-acetylcysteine could play a substantial role in germ cell survival. This follows a report by Erkkilä et al. (1998) that N-acetylcysteine plays an important role in germ cell survival in human seminiferous tubules in an in-vitro study.

The histone retention seen in the cyclophosphamide-treated group is consistent with the report by Codrington et al. (2004; 2007) that the toxicity effects of cyclophosphamide is a stage-specific effect which is maximal during mid-spermiogenesis, a stage characterized with histone hyperacetylation and histone displacement. Matching the ameliorated histone-protamine replacement with the observed fair DNA integrity in rats treated with both Cyclophosphamide and N-acetylcysteine; N-acetylcysteine could exert part of its effects through the phosphorylated H2AX Histone - an important protein in histone-protamine replacement and DNA single strand break repair. N-acetylcysteine has been reported to enhance H2AX phosphorylation in cells exposed to doxorubicin (Kurz et al., 2004).

Apoptosis is a programmed cell death that is regulated at the cellular level and progress by activation of some cysteine aspartyl-specific protease (Caspases) (Häcker, 2000). It is characterized by membrane blebbing, cell volume shrinkage, chromatin condensation, cytoplasmic vacuolization and disassembly of the cell into membrane-bound remnants, termed apoptotic bodies (Majno & Joris, 1995) that are eventually picked up by phagocytic cells. The initiation of caspase activation may happen either via the mitochondria (intrinsic), or through a cell-death receptor (extrinsic) (Igney & Krammer, 2002), Granzyme (Martinvalet et al., 2005), or via the endoplasmic reticulum (Szegezdi et al., 2003); however, the primary effector of chemotherapy-induced apoptosis is the mitochondria pathway (Debatin et al., 2002). In the mitochondria pathway, the intracellular susceptibility to apoptosis depends on the signal received from a damaged DNA component and the interaction between pro-apoptotic protein, majorly BAX and other anti-apoptotic protein of the Bcl-2 family (Farrow & Brown, 1996).

The altered DNA integrity observed in animals treated with cyclophosphamide in this study indicates the vulnerability of their germ cells to apoptosis. This is consistent with the report from Basu & Haldar (1998) that DNA damage is one of the signals for the progression of apoptosis. The reduced BAX expression seen in the animals treated with cyclophosphamide in this study is also consistent with earlier reports of reduced BAX expression following the exposure of prostate (Haldar et al., 1996) or breast (Srivastava et al., 1998) cancer cells to Taxol - a chemotherapeutic agent. Matching the expression of BAX protein in these groups treated with cyclophosphamide with their altered chromatin integrity and degraded seminiferous tubules may hint that apoptosis have occurred in a pathway independent of Bax protein. This is in line with the results from Russell et al. (2002), who reported the occurrence of testicular atrophy and degeneration of germ cells in BAX-deficient mice. It has also been documented in an in-vitro study by Krajewski et al. (1996) that for most anticancer drugs, elevation of the Bcl-2/BAX ratio due to changes in the expression of any of the proteins do not prevent drug-induced apoptosis.

On the other hand, a normal testicular morphometry and intact chromatin matched with high BAX expression observed in the control and N-acetylcysteine-treated groups might probably be due to the regulatory role of BAX proteins in germ cell survival (Rodriguez et al., 1997; Rucker et al., 2000; Russell et al., 2002).

CONCLUSION

N-acetylcysteine may improve sperm histone-protamine replacement, which is one of the stage-specific effects of cyclophosphamide toxicity during spermatogenesis. Understanding the role of N-acetylcysteine in the amelioration of sperm DNA damage, particularly in the repair of DNA single stand breakage in cyclophosphamide toxicity might prove it a promising adjunct drug.

Footnotes

Convention where the study was presented

This abstract was presented in the 37th Annual Scientific Conference of Physiological Society of Nigeria (PSN), Enugu, Nigeria. 16th - 21th September 2015.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest

REFERENCES

  1. Alkam T, Chebolu S, Darmani NA. Cyclophosphamide causes activation of protein kinase A (PKA) in the brainstem of vomiting least shrews (Cryptotis parva) Eur J Pharmacol. 2014;722:156–164. doi: 10.1016/j.ejphar.2013.09.080. [DOI] [PubMed] [Google Scholar]
  2. Al-Tonbary Y, Al-Haggar M, El-Ashry R, El-Dakroory S, Azzam H, Fouda A. Vitamin E and N-acetylecystein as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia. Adv Hematol. 2009:689639–689639. doi: 10.1155/2009/689639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alyamkina EA, Nikolin VP, Popova NA, Dolgova EV, Proskurina AS, Orishchenko KE, Efremov YR, Chernykh ER, Ostanin AA, Sidorov SV, Ponomarenko DM, Zagrebelniy SN, Bogachev SS, Shurdov MA. A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation. Genet Vaccines Ther. 2010;8(7) doi: 10.1186/1479-0556-8-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ankem MK, Mayer E, Ward WS, Cummings KB, Barone JG. Novel assay for determining DNA organization in human spermatozoa: implications for male factor infertility. Urology. 2002;59:575–578. doi: 10.1016/S0090-4295(01)01619-3. [DOI] [PubMed] [Google Scholar]
  5. Arora-Kuruganti P, Lucchesi PA, Wurster RD. Proliferation of cultured human astrocytoma cells in response to an oxidant and antioxidant. J. Neurooncol. 1999;44:213–221. doi: 10.1023/A:1006315332098. [DOI] [PubMed] [Google Scholar]
  6. Basu A, Haldar S. The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod. 1998;4:1099–1109. doi: 10.1093/molehr/4.12.1099. [DOI] [PubMed] [Google Scholar]
  7. Bianchi PG, Manicardi GC, Urner F, Campana A, Sakkas D. Chromatin packaging and morphology in ejaculated human spermatozoa: evidence of hidden anomalies in normal spermatozoa. Mol Hum Reprod. 1996;2:139–144. doi: 10.1093/molehr/2.3.139. [DOI] [PubMed] [Google Scholar]
  8. Blanchard CG, Labrecque BA, Ruckdeschel JC, Blanchard EB. Physician behaviours, patient perceptions, and patient characteristics as predictors of satisfaction of hospitalised adult cancer patients. Cancer. 1990;65:186–192. doi: 10.1002/1097-0142(19900101)65:1&#x0003c;186::AID-CNCR2820650136&#x0003e;3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  9. Calvin HI, Bedford JM. Formation of disulphide bonds in the nucleus and accessory structures of mammalian spermatozoa during maturation in the epididymis. J Reprod Fertil Suppl. 1971;13:65–75. [PubMed] [Google Scholar]
  10. Chiao JW, Chung F, Krzeminski J, Amin S, Arshad R, Ahmed T, Conaway CC. Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate. Int J Oncol. 2000;16:1215–1219. doi: 10.3892/ijo.16.6.1215. [DOI] [PubMed] [Google Scholar]
  11. Codrington A, Hales B, Robaire B. Spermiogenic germ cell phase-specific DNA damage following cyclophosphamide exposure. J Androl. 2004;25:354–362. doi: 10.1002/j.1939-4640.2004.tb02800.x. [DOI] [PubMed] [Google Scholar]
  12. Codrington AM, Hales BF, Robaire B. Exposure of male rats to cyclophosphamide alters the chromatin structure and basic proteome in spermatozoa. Hum Reprod. 2007;22:1431–1442. doi: 10.1093/humrep/dem002. [DOI] [PubMed] [Google Scholar]
  13. Debatin KM, Poncet D, Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene. 2002;21:8786–8803. doi: 10.1038/sj.onc.1206039. [DOI] [PubMed] [Google Scholar]
  14. Erenpreiss J, Bars J, Lipatnikova V, Erenpreisa J, Zalkalns J. Comparative study of cytochemical tests for sperm chromatin integrity. J Androl. 2001;22:45–53. doi: 10.1002/j.1939-4640.2001.tb02152.x. [DOI] [PubMed] [Google Scholar]
  15. Erkkilä K, Hirvonen V, Wuokko E, Parvinen M, Dunkel L. N-acetyl-L cysteine inhibits apoptosis in human male germ cells in vitro. J Clin Endocrinol Metab. 1998;83:2523–2531. doi: 10.1210/jcem.83.7.4949. [DOI] [PubMed] [Google Scholar]
  16. Evenson DP, Jost LK, Marshall D, Zinaman MJ, Clegg E, Purvis K, de Angelis P, Claussen OP. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod. 1999;14:1039–1049. doi: 10.1093/humrep/14.4.1039. [DOI] [PubMed] [Google Scholar]
  17. Evenson DP, Larson KL, Jost LK. Sperm chromatin structure assay: its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. J Androl. 2002;23:25–43. doi: 10.1002/j.1939-4640.2002.tb02599.x. [DOI] [PubMed] [Google Scholar]
  18. Farombi EO, Ugwuezunmba MC, Ezenwadu TT, Oyeyemi MO, Ekor M. Tetracycline-induced reproductive toxicity in male rats: effects of vitamin C and N-acetylcysteine. Exp Toxicol Pathol. 2008;60:77–85. doi: 10.1016/j.etp.2008.02.002. [DOI] [PubMed] [Google Scholar]
  19. Farrow SN, Brown R. New members of the Bcl-2 family and their protein partners. Curr Opinion Genet Dev. 1996;6:45–49. doi: 10.1016/S0959-437X(96)90009-X. [DOI] [PubMed] [Google Scholar]
  20. Georgiou I, Syrrou M, Pardalidis N, Karakitsios K, Mantzavinos T, Giotitsas N, Loutradis D, Dimitriadis F, Saito M, Miyagawa I, Tzoumis P, Sylakos A, Kanakas N, Moustakareas T, Baltogiannis D, Touloupides S, Giannakis D, Fatouros M, Sofikitis N. Genetic and epigenetic risks of intracytoplasmic sperm injection method. Asian J Androl. 2006;8:643–673. doi: 10.1111/j.1745-7262.2006.00231.x. [DOI] [PubMed] [Google Scholar]
  21. Häcker G. The morphology of apoptosis. Cell Tissue Res. 2000;301:5–17. doi: 10.1007/s004410000193. [DOI] [PubMed] [Google Scholar]
  22. Haldar S, Chintapalli J, Croce CM. Taxol induces Bcl2 phosphorylation and death of prostate cancer cells. Cancer Res. 1996;56:1253–1255. [PubMed] [Google Scholar]
  23. Howell SJ, Radford JA, Ryder WD, Shalet SM. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. J Clin Oncol. 1999;17:1493–1498. doi: 10.1200/JCO.1999.17.5.1493. [DOI] [PubMed] [Google Scholar]
  24. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277–288. doi: 10.1038/nrc776. [DOI] [PubMed] [Google Scholar]
  25. Jamshidzadeh A, Niknahad H, Azarpira N, Mohammadi-Bardbori A, Delnavaz M. Effect of Lycopene on Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats. Iran J Med Sci. 2009;34:46–52. [Google Scholar]
  26. Kosower NS, Katayose H, Yanagimuchi RJN. Thiol-disulfide status and acridine orange fluorescence of mammalian sperm nuclei. J Androl. 1992;13:342–348. doi: 10.1002/j.1939-4640.1992.tb00335.x. [DOI] [PubMed] [Google Scholar]
  27. Krajewski S, Krajewska M, Reed JC. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res. 1996;56:2849–2855. [PubMed] [Google Scholar]
  28. Kurz EU, Douglas P, Lees-Miller SP. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J Biol Chem. 2004;279:53272–53281. doi: 10.1074/jbc.M406879200. [DOI] [PubMed] [Google Scholar]
  29. Lolis D, Georgiou I, Syrrou M, Zikopoulos K, Konstantelli M, Messinis I. Chromomycin A3-staining as an indicator of protamine deficiency and fertilization. Int J Androl. 1996;19:23–27. doi: 10.1111/j.1365-2605.1996.tb00429.x. [DOI] [PubMed] [Google Scholar]
  30. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995;146:3–15. [PMC free article] [PubMed] [Google Scholar]
  31. Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity. 2005;22:355–370. doi: 10.1016/j.immuni.2005.02.004. [DOI] [PubMed] [Google Scholar]
  32. Mello M. Induced metachromasia in bull spermatozoa. Histochemistry. 1982;74:387–392. doi: 10.1007/BF00493438. [DOI] [PubMed] [Google Scholar]
  33. Montellier E, Boussouar F, Rousseaux S, Zhang K, Buchou T, Fenaille F, Shiota H, Debernardi A, Héry P, Curtet S, Jamshidikia M, Barral S, Holota H, Bergon A, Lopez F, Guardiola P, Pernet K, Imbert J, Petosa C, Tan M, Zhao Y, Gérard M, Khochbin S. Chromatin-to-nucleoprotamine transition is controlled by the histone H2B variant TH2B. Genes Dev. 2013;27:1680–1692. doi: 10.1101/gad.220095.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Moschou M, Kosmidis EK, Kaloyianni M, Geronikaki A, Dabarakis N, Theophilidis G. In vitro assessment of the neurotoxic and neuroprotective effects of N-acetyl-L-cysteine (NAC) on the rat sciatic nerve fibers. Toxicol In Vitro. 2008;22:267–274. doi: 10.1016/j.tiv.2007.09.005. [DOI] [PubMed] [Google Scholar]
  35. Oliva R. Protamines and male infertility. Hum Reprod Update. 2006;12:417–435. doi: 10.1093/humupd/dml009. [DOI] [PubMed] [Google Scholar]
  36. Pallares J, Bussaglia E, Martínez-Guitarte JL, Dolcet X, Llobet D, Rue M, Sanchez-Verde L, Palacios J, Prat J, Matias-Guiu X. Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities. Mod Patol. 2005;18:719–727. doi: 10.1038/modpathol.3800347. [DOI] [PubMed] [Google Scholar]
  37. Raji Y, Akinsomisoye OS, Salman TM. Antispermatogenic activity of Morinda lucida extract in male rats. Asian J Androl. 2005;7:405–410. doi: 10.1111/j.1745-7262.2005.00051.x. [DOI] [PubMed] [Google Scholar]
  38. Rodriguez I, Ody C, Araki K, Garcia I, Vassalli P. An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO J. 1997;16:2262–2270. doi: 10.1093/emboj/16.9.2262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rosenborg L, Rao KM, Björndahl L, Kvist U, Pousette A, Akerlöf E, Fredricsson B. Changes in human sperm chromatin stability during preparation for in-vitro fertilization. Int J Androl. 1990;13:287–296. doi: 10.1111/j.1365-2605.1990.tb01034.x. [DOI] [PubMed] [Google Scholar]
  40. Rucker 3rd EB, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, Flaws JA, Hennighausen L. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol. 2000;14:1038–1052. doi: 10.1210/mend.14.7.0465. [DOI] [PubMed] [Google Scholar]
  41. Russell LD, Chiarini-Garcia H, Korsmeyer SJ, Knudson CM. Bax-dependent spermatogonia apoptosis is required for testicular development and spermatogenesis. Biol Reprod. 2002;66:950–958. doi: 10.1095/biolreprod66.4.950. [DOI] [PubMed] [Google Scholar]
  42. Sega GA. Molecular targets, DNA breakage, and DNA repair: their role in mutation induction in mammalian germ cells. In: Allen JW, Bridges BA, Lyon MF, Moses MJ, Russell LB, editors. Biology of Mammalian Germ Cell Mutagenesis. Banbury Report 34. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1990. pp. 79–91. [Google Scholar]
  43. Spermon JR, Ramos L, Wetzels AM, Sweep CG, Braat DD, Kiemeney LA, Witjes JA. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Hum Reprod. 2006;21:1781–1786. doi: 10.1093/humrep/del084. [DOI] [PubMed] [Google Scholar]
  44. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol. 1998;18:3509–3517. doi: 10.1128/MCB.18.6.3509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Steger K, Fink L, Failing K, Bohle RM, Kliesch S, Weidner W, Bergmann M. Oecreased protamine-1 transcript levels in testes from infertile men. Mol Hum Reprod. 2003;9:331–336. doi: 10.1093/molehr/gag041. [DOI] [PubMed] [Google Scholar]
  46. Szegezdi E, Fitzgerald U, Samali Caspase-12 and ER stress mediated apoptosis: the story so far. Ann NY Acad Sci. 2003;1010:186–194. doi: 10.1196/annals.1299.032. [DOI] [PubMed] [Google Scholar]
  47. Wang Z, Jiang H, Chen S, Du F, Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell. 2012;148:228–243. doi: 10.1016/j.cell.2011.11.030. [DOI] [PubMed] [Google Scholar]
  48. Wong A, Chuan SS, Patton WC, Jacobson JD, Corselli J, Chan PJ. Addition of eosin to the aniline blue assay to enhance detection of immature sperm histones. Fertil Steril. 2008;90:1999–2002. doi: 10.1016/j.fertnstert.2007.09.026. [DOI] [PubMed] [Google Scholar]

Articles from JBRA Assisted Reproduction are provided here courtesy of Brazilian Society of Assisted Reproduction

RESOURCES